Preview Mode Links will not work in preview mode

Aug 8, 2020

Discussing the Impact of the Pandemic on the Management of Lung, Breast, Gastrointestinal and Genitourinary Cancers — Part 4: Interview with Dr Oh on the following topics:

  • Management of genitourinary cancers during the COVID-19 era (00:00)
  • Case (Dr Oh): A man in his early 80s with metastatic castration-resistant...


Apr 20, 2020

A roundtable discussion about prostate cancer featuring perspectives from Drs Neeraj Agarwal, Emmanuel S Antonarakis and A Oliver Sartor.

  • Integrating PARP inhibitors into the treatment algorithm for patients with prostate cancer (PC) (00:00)
  • Role of PARP enzymes in DNA damage repair and mechanism of action of PARP...


Apr 20, 2020

Exploring the Current and Future Role of PARP Inhibition in the Management of Prostate Cancer — Part 1: Featuring slide presentations and discussion with Dr Antonarakis.

  • Genomic Landscape of Prostate Cancer; Incidence of DNA Damage Repair Deficiencies and the Biology of PARP Inhibition
    • Faculty Presentation — Dr...


Apr 20, 2020

Exploring the Current and Future Role of PARP Inhibition in the Management of Prostate Cancer — Part 2: Featuring slide presentations and discussion with Dr Sartor.

  • Current Data with PARP Inhibitor Monotherapy in Metastatic Castration-Resistant Prostate Cancer
    • Faculty Presentation — Dr Sartor (00:00)
    • Discussion...


Apr 20, 2020

Exploring the Current and Future Role of PARP Inhibition in the Management of Prostate Cancer — Part 3: Featuring slide presentations and discussion with Dr Agarwal.

  • Novel Combination Approaches with PARP Inhibitors: Rationale and Ongoing Research
    • Faculty Presentation — Dr Agarwal (00:00)
    • Discussion (28:26)